Latest news
IMRX Stock On Track For Worst Day In Nearly 5 Months — What’s Driving The Selloff? - StocktwitsStocktwits · Fri, 07 Aug 2026 18:34:48 GMTIMMUNEERING CORPORATION : H.C. WAINWRIGHT INITIATES COVERAGE WITH BUY RATING - BitgetBitget · Thu, 06 Aug 2026 23:25:51 GMTH.C. Wainwright Initiates Immuneering(IMRX.US) With Buy Rating, Announces Target Price $14 - MoomooMoomoo · Thu, 06 Aug 2026 20:00:48 GMTImmuneering Corporation Stock 12‑Month Price Target Cut to $17.57, Implies 300% Upside - TradingViewTradingView · Thu, 06 Aug 2026 17:20:18 GMTH.C. Wainwright Starts Immuneering Corporation (IMRX) at Buy - StreetInsiderStreetInsider · Thu, 06 Aug 2026 10:12:22 GMTImmuneering Releases Q2 2026 Financial Results - AlphaStreetAlphaStreet · Wed, 05 Aug 2026 14:47:08 GMTImmuneering Corp 2026: Revenue ($17.44M), Net income ($17.27M), EPS ($0.27) — 10-Q Summary - TradingViewTradingView · Wed, 05 Aug 2026 12:01:01 GMTIMRX: Advanced pivotal trial for atebimetinib, strong cash runway, and widened net loss on higher R&D - TradingViewTradingView · Wed, 05 Aug 2026 11:43:32 GMT